8-K: Adtalem Global Education Refutes Claims Made by Safkhet Capital in Recent Report

Adtalem Global Education has issued a press release strongly refuting claims made by Safkhet Capital in a report that the company says contains numerous factual errors and misrepresentations.

Summary

• Adtalem Global Education has responded to a report by Safkhet Capital, which they claim contains numerous factual errors and misrepresentations.
• Adtalem asserts that the Safkhet Capital report demonstrates a poor understanding of the education industry and basic accounting principles.
• The company specifically addresses several claims made by Safkhet Capital, including those related to the Walden acquisition, enrollment trends, graduation rates, and compliance with regulatory rules.
• Adtalem states that its total enrollment increased by 6% as of December 31, 2023, the largest increase since acquiring Walden in August 2021.
• They also highlight that Chamberlain University's four-year graduation rate of 71% for all full-time undergraduate students is substantially higher than the national average of 49%.
• Adtalem clarifies that the $1.48 billion acquisition of Walden was appropriately accounted for, with intangible assets and goodwill tested for impairment annually.
• The company also addresses claims about the gainful employment rule, the 90/10 rule, and a Department of Education investigation into Walden, stating that they are in compliance and cooperating fully.
• Adtalem emphasizes that there is no evidence of material risk from the borrower defense program and that they have a $340 million cap on liability relating to DeVry, only a portion of which has been incurred.
• They also refute claims about expired program participation agreements and share buybacks, stating that they are in good standing with the Department of Education and take a balanced approach to capital allocation.
• Adtalem believes that the updated executive compensation policy aligns management incentives with shareholder value through revenue growth and EBITDA margin metrics.

Sentiment

Score: 4

Explanation: The document is primarily defensive, responding to a critical report. While Adtalem presents positive data, the need to refute claims suggests underlying concerns and potential risks.

Positives

• Adtalem's total enrollment has increased, showing positive growth trends.
• Chamberlain University's graduation rates are significantly higher than the national average.
• The Walden acquisition is performing well, with no impairment issues identified.
• Adtalem is confident in its compliance with the gainful employment and 90/10 rules.
• The company is actively cooperating with the Department of Education investigation into Walden.
• Adtalem has a cap on liability related to DeVry, limiting potential financial exposure.
• The executive compensation policy is aligned with shareholder value.

Negatives

• A short seller report has raised concerns about Adtalem's business practices and financial health.
• Walden University is under investigation by the Department of Education.
• The Ross University School of Veterinary Medicine DVM program may need to adjust pricing to maintain Title IV eligibility if the Department of Education does not include DVM programs in the extended earnings window.

Risks

• The Department of Education investigation into Walden could potentially lead to future issues.
• The gainful employment rule could impact some of Adtalem's programs if not managed effectively.
• The litigation seeking to block enforcement of the gainful employment rule could create uncertainty.
• The Ross University School of Veterinary Medicine DVM program may need to adjust pricing to maintain Title IV eligibility.
• Negative publicity from the short seller report could impact investor confidence.

Future Outlook

Adtalem anticipates a return to total enrollment growth in its medical schools in fiscal 2025 and expects its degree programs to pass the Department of Education's gainful employment rule. They also expect certain Walden clinical psychology and clinical counseling programs to benefit from the extended earnings window in the final GE rule.

Management Comments

• Adtalem President and CEO Steve Beard stated that the Safkhet Capital report is a reckless attempt to defame the nation's largest healthcare educator.
• Management believes that revenue growth and EBITDA margin are closely correlated with shareholder value.

Industry Context

The response to the short seller report highlights the scrutiny faced by for-profit education companies and the importance of regulatory compliance and transparency. The company is positioning itself as a leader in healthcare education with a focus on strong student outcomes.

Comparison to Industry Standards

• Adtalem's Chamberlain University's four-year graduation rate of 71% for all full-time undergraduate students is substantially higher than the national average of 49% across all four-year institutions.
• The company states that its graduation rates compare favorably to benchmarks across non-profit, public, private, and proprietary institutions.
• Adtalem highlights that it produces more nursing and Doctor of Veterinary Medicine (DVM) graduates than any institution in the U.S., and awards more medical and research doctoral degrees to African Americans than any other U.S. institution.
• The company also notes that it has achieved 98% first-time residency attainment for graduates of its medical schools last year.

Legal Proceedings

• Walden University received a notice of investigation and request for information from the Department of Education.

Stakeholder Impact

• The short seller report and Adtalem's response may impact shareholder confidence and the company's stock price.
• The Department of Education investigation into Walden could affect students and faculty.
• The gainful employment rule and other regulatory issues could impact the company's ability to operate and provide education.
• The company's response aims to reassure stakeholders about its financial health and operational integrity.

Next Steps

• Adtalem will continue to cooperate with the Department of Education investigation into Walden.
• The company will continue to monitor and comply with the gainful employment rule.
• Adtalem will continue to urge the Department of Education to include DVM programs in the extended earnings window.
• The company will continue to execute its remediation plan for medical school enrollment.

Key Dates

Keywords

Adtalem Global Education, Safkhet Capital, Walden University, Enrollment, Graduation Rates, Gainful Employment Rule, 90/10 Rule, Department of Education, Short Seller, Healthcare Education